Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma
Authors:
- 18 August 2016
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 48 (4) , 1052-1062
Abstract
The effect of systemic inflammation and comorbidities on treatment and outcome of adult-onset asthma remains unknown and is the objective of this study.As part of the Seinäjoki Adult Asthma Study (SAAS) with a 12-year follow-up, serum interleukin (IL)-6, high-sensitivity C-reactive protein (hsCRP) and lung function were measured and clinical information on comorbidities and medication collected from 170 patients with adult-onset asthma without chronic obstructive pulmonary disease.At follow-up visit, 54% of the patients had systemic inflammation as indicated by elevated IL-6 or hsCRP, 58% had at least one comorbidity and 30% at least two comorbidities (other than asthma related). Patients with systemic inflammation were treated with higher dose of inhaled corticosteroid (ICS) and they had lower lung function and higher blood neutrophils compared with patients without. Patients having ≥2 comorbidities had lower Asthma Control Test score and this association remained significant in adjusted analysis. Patients with both systemic inflammation and comorbidities showed poorest outcome of asthma. In multivariate regression analysis, high ICS dose was predicted by elevated IL-6, elevated blood neutrophils and eosinophils and poorer lung function at baseline and follow-up.Altogether, in patients with adult-onset asthma, elevated IL-6 was associated with use of high-dose ICS while multi-morbidity was linked to worse symptoms of asthma.Keywords
Funding Information
- the Medical Research Fund of Seinäjoki Central Hospital
- The competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital
- Tampere Tuberculosis Foundation
- Finnish Anti-Tuberculosis Association Foundation
- Jalmari and Rauha Ahokas Foundation
This publication has 43 references indexed in Scilit:
- Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and MechanismsMediators of Inflammation, 2016
- Prognosis of new-onset asthma diagnosed at adult ageRespiratory Medicine, 2015
- Phenotypes, Risk Factors, and Mechanisms of Adult‐Onset AsthmaMediators of Inflammation, 2015
- Obesity and symptoms of depression contribute independently to the poor asthma control of obesityRespiratory Medicine, 2014
- Three phenotypes of adult‐onset asthmaAllergy, 2013
- Asthma phenotypes: the evolution from clinical to molecular approachesNature Medicine, 2012
- Long-term studies of the natural history of asthma in childhoodJournal of Allergy and Clinical Immunology, 2010
- Burden of comorbidity in individuals with asthmaThorax, 2010
- What Is Worse for Asthma Control and Quality of LifeChest, 2006
- The influence of co-morbidity on health-related quality of life in asthma and COPD patientsRespiratory Medicine, 2003